Erchonia Corporation Wins Default Judgment in Green Laser Patent Case

📄 View Full Report 📥 Export PDF 🔗 Share ⭐ Save

📋 Case Summary

Case NameErchonia Corporation LLC v. The Partnerships and Unincorporated Associations Identified on Schedule A
Case Number1:25-cv-10560 (N.D. Ill.)
CourtU.S. District Court for the Northern District of Illinois
DurationSep 2025 – Jan 2026 140 days
OutcomePlaintiff Win — Permanent Injunction
Patents at Issue
Accused ProductsLuxMaster Slim, Maxlipo Master, and Glaser green laser devices

Case Overview

In a decisive outcome for medical device patent holders, the U.S. District Court for the Northern District of Illinois entered a **default judgment and permanent injunction** against multiple unnamed online sellers in *Erchonia Corporation LLC v. The Partnerships and Unincorporated Associations Identified on Schedule A* (Case No. 1:25-cv-10560). The ruling, issued January 21, 2026, just 140 days after filing, permanently bars defendants from manufacturing, selling, or advertising the **LuxMaster Slim, Maxlipo Master, and Glaser** green laser devices — products alleged to infringe two Erchonia patents covering low-level laser therapy (LLLT) technology.

The case is a textbook example of an increasingly common enforcement strategy: using Schedule A mass-defendant litigation to swiftly neutralize offshore marketplace sellers on platforms like AliExpress, Alibaba, and DHGate. For patent attorneys, IP professionals, and R&D teams operating in the medical device and aesthetic laser space, this outcome carries significant strategic weight.

The Parties

⚖️ Plaintiff

Recognized innovator in low-level laser therapy, holding a substantial portfolio of patents related to non-invasive body contouring and therapeutic laser devices.

🛡️ Defendant

Anonymous network of online sellers, a structure commonly used in Schedule A IP enforcement actions to consolidate claims against multiple infringers.

The Patents at Issue

Two U.S. patents formed the basis of Erchonia’s infringement claims. Both patents relate to **green laser technology** applied in non-invasive body contouring and aesthetic medical procedures — a commercially valuable and competitive market segment.

  • US7947067B2 — Covers foundational laser therapy device architecture and methodology
  • US9149650B2 — Covers refined LLLT system configurations and treatment protocols
🔍

Developing a green laser device?

Check if your low-level laser therapy product might infringe these or related patents before launch.

Run FTO Check →

Litigation Timeline & Procedural History

Complaint FiledSeptember 3, 2025
Default Judgment EnteredJanuary 21, 2026
Total Duration140 days
Court & JudgeN.D. Illinois, Chief Judge Andrea R. Wood

The case was filed in the **Northern District of Illinois**, a venue frequently selected for Schedule A patent enforcement actions due to its established procedural familiarity with e-commerce IP cases and its capacity to issue emergency ex parte relief, including temporary restraining orders and asset freezes.

Presiding over the matter was **Chief Judge Andrea R. Wood**, whose court handled the case efficiently from filing through final judgment in fewer than five months — a notably fast resolution consistent with uncontested default proceedings.

The 140-day duration reflects the absence of any substantive defense. When defendants fail to appear or respond, courts can proceed to default judgment without the procedural overhead of claim construction hearings, expert discovery, or trial. The $10,000 bond posted by Erchonia — standard in preliminary injunction proceedings — was ordered released back to plaintiff upon final judgment.

Reference: Case docket accessible via PACER under Case No. 1:25-cv-10560, N.D. Ill.

The Verdict & Legal Analysis

Outcome

Chief Judge Andrea R. Wood **granted Erchonia’s Motion for Entry of Default and Default Judgment in full**, entering a **permanent injunction** against all defaulting defendants. The court’s order:

  • Deemed all non-appearing defendants **in default**
  • Permanently enjoined defendants from making, using, selling, or offering for sale the LuxMaster Slim, Maxlipo Master, and Glaser products
  • Extended injunctive reach to **third-party platform providers**, including AliExpress, Alibaba, DHGate, Made-In-China, and Aimylin.com
  • Required compliance within **seven calendar days** of order receipt
  • Ordered the $10,000 preliminary injunction bond released to Erchonia

No specific damages award was disclosed in the available case data, which is not atypical in default judgment proceedings where the primary remedy sought is injunctive rather than compensatory.

Verdict Cause Analysis

The legal basis was a straightforward **patent infringement action** under 35 U.S.C. § 271. Because defendants failed to appear, the court accepted Erchonia’s well-pleaded allegations as admitted, consistent with the standard applied under Federal Rule of Civil Procedure 55(b). There was no contested claim construction, no validity challenge, and no infringement rebuttal.

The strategic significance lies not in legal complexity but in **procedural precision**: Erchonia’s legal team structured the complaint and default motion to satisfy all elements required for injunctive relief — likelihood of irreparable harm, inadequacy of monetary damages, balance of hardships, and public interest — thereby securing the broadest possible enforcement mechanism.

Legal Significance

While default judgments carry **limited precedential value** for substantive patent law, this ruling is procedurally instructive for several reasons:

  • Third-party platform orders — The court’s direct targeting of AliExpress, Alibaba, DHGate, and similar platforms as enjoined third parties reinforces the viability of this enforcement mechanism under *Tiffany v. eBay* progeny, extending injunctive reach beyond named defendants to the commercial infrastructure enabling infringement.
  • Schedule A mass-defendant structure — The case exemplifies how patent holders can efficiently consolidate claims against diffuse offshore seller networks, reducing per-defendant litigation cost while maximizing marketplace disruption.
  • Asset discovery mechanism — The order’s provision allowing Erchonia to serve supplemental proceedings via email for subsequently identified accounts reflects courts’ adaptation to the realities of anonymous e-commerce enforcement.
⚠️

Freedom to Operate (FTO) Analysis

This case highlights critical IP risks in the medical device and aesthetic laser market. Choose your next step:

📋 Understand This Case’s Impact

Learn about the specific risks and implications from this litigation for LLLT devices.

  • View all related patents in this technology space
  • See which companies are most active in green laser patents
  • Understand claim construction patterns for LLLT
📊 View Patent Landscape
⚠️
High Risk Area

Green laser body contouring devices

📋
Active Patent Portfolio

Erchonia’s LLLT patents (US7947067B2, US9149650B2)

Design-Around Options

Possible with careful analysis

✅ Key Takeaways

For Patent Attorneys & Litigators

Default judgment proceedings in Schedule A cases can deliver permanent injunctions in under 150 days.

Search related case law →

Third-party platform injunctions are a powerful and court-approved enforcement extension against online infringers.

Explore enforcement strategies →
🔒
Unlock Strategic Guidance for IP & R&D Teams
Get actionable IP strategy steps for medical device product teams, including FTO timing guidance and competitive intelligence best practices.
FTO Timing Guidance Competitive Landscape Analysis Product Naming Risks
Explore Full Analysis in PatSnap Eureka

Frequently Asked Questions

Ready to Strengthen Your Patent Strategy in Medical Devices?

Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision in the LLLT space.

PatSnap IP Intelligence Team

Patent Research & Competitive Intelligence · PatSnap

This analysis was produced by the PatSnap IP Intelligence Team — a group of patent analysts, IP strategists, and data scientists who work daily with PatSnap’s global patent database of over 2 billion structured data points across patents, litigation records, scientific literature, and regulatory filings.

The team specialises in tracking landmark litigation outcomes, translating complex court rulings into actionable IP strategy, and identifying the competitive intelligence implications for R&D and legal teams. All case analysis is grounded in primary sources: official court records, USPTO filings, and Federal Circuit opinions.

📊 2B+ Patent Data Points 🌍 120+ Countries Covered 🏢 18,000+ Customers Worldwide ⚖️ Global Litigation Database 🔍 Primary Source Verified

References

  1. PACER — Case No. 1:25-cv-10560, N.D. Ill.
  2. USPTO Patent Full-Text Database (via Google Patents)

This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.

⚖️ Disclaimer: This article is for informational purposes only and does not constitute legal advice. The analysis presented reflects publicly available case information and general legal principles. For specific advice regarding patent litigation, FTO analysis, or IP strategy, please consult a qualified patent attorney.